BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28301598)

  • 1. Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2.
    Basu A; Sridharan S
    PLoS One; 2017; 12(3):e0173854. PubMed ID: 28301598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S6 kinase 2 promotes breast cancer cell survival via Akt.
    Sridharan S; Basu A
    Cancer Res; 2011 Apr; 71(7):2590-9. PubMed ID: 21427355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-eta regulates Mcl-1 level via ERK1.
    Pal D; Basu A
    Cell Signal; 2017 Dec; 40():166-171. PubMed ID: 28939105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polyproline-motif of S6K2: eIF5A translational dependence and importance for protein-protein interactions.
    Meneguello L; Barbosa NM; Pereira KD; Proença ARG; Tamborlin L; Simabuco FM; Iwai LK; Zanelli CF; Valentini SR; Luchessi AD
    J Cell Biochem; 2019 Apr; 120(4):6015-6025. PubMed ID: 30320934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
    Karlsson E; Magić I; Bostner J; Dyrager C; Lysholm F; Hallbeck AL; Stål O; Lundström P
    PLoS One; 2015; 10(12):e0145013. PubMed ID: 26698305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
    Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
    Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
    Song J; Chen Q; Xing D
    Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ribosomal S6 kinase 2 by effectors of the phosphoinositide 3-kinase pathway.
    Martin KA; Schalm SS; Richardson C; Romanelli A; Keon KL; Blenis J
    J Biol Chem; 2001 Mar; 276(11):7884-91. PubMed ID: 11108711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypeptide antibiotic actinomycin D induces Mcl-1 uncanonical downregulation in lung cancer cell apoptosis.
    Chen CL; Tseng PC; Chao YP; Shen TJ; Jhan MK; Wang YT; Nguyen TT; Lin CF
    Life Sci; 2023 May; 321():121615. PubMed ID: 37001403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of S6K2, a novel kinase homologous to S6K1.
    Lee-Fruman KK; Kuo CJ; Lippincott J; Terada N; Blenis J
    Oncogene; 1999 Sep; 18(36):5108-14. PubMed ID: 10490847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
    Tanaka T; Kikuchi N; Goto K; Iino M
    Apoptosis; 2016 May; 21(5):594-608. PubMed ID: 26892009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells.
    Choi HN; Jin HO; Kim JH; Hong SE; Kim HA; Kim EK; Lee JK; Park IC; Noh WC
    Biochem Biophys Res Commun; 2013 Mar; 432(1):123-8. PubMed ID: 23376066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of S6K2 as a centrosome-located kinase.
    Rossi R; Pester JM; McDowell M; Soza S; Montecucco A; Lee-Fruman KK
    FEBS Lett; 2007 Aug; 581(21):4058-64. PubMed ID: 17678899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
    Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
    J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
    Sun NK; Huang SL; Chang TC; Chao CC
    J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
    Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
    Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S6K2 promises an important therapeutic potential for cancer.
    Sever Nİ; Cengiz Şahin S
    Future Oncol; 2019 Jan; 15(1):95-102. PubMed ID: 30730779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death.
    Eichhorn JM; Sakurikar N; Alford SE; Chu R; Chambers TC
    Cell Death Dis; 2013 Oct; 4(10):e834. PubMed ID: 24091677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.
    Inoue-Yamauchi A; Jeng PS; Kim K; Chen HC; Han S; Ganesan YT; Ishizawa K; Jebiwott S; Dong Y; Pietanza MC; Hellmann MD; Kris MG; Hsieh JJ; Cheng EH
    Nat Commun; 2017 Jul; 8():16078. PubMed ID: 28714472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.